Dernières nouvelles pour Mainz Biomed (NASDAQ:MYNZ) Stock

Mainz Biomed

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

Mainz Biomed NV

Raymond James has initiated coverage on Super Micro Computer (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) with an Outperform rating. This move comes in light of Supermicro&#8217;s strong standing in the AI-optimized infrastructure sector and its swift revenue growth.
What Happened: AI platforms constitute approximately 70% of Supermicro&#8217;s revenue, positioning it as a dominant player among branded server vendors. Raymond James has set a $41 price target for the company, projecting Supermicro&#8217;s FY26 revenue at $29.8 billion with an EPS of $3.03, indicating a compound annual growth rate (CAGR) of over 25%, <a href="https://in.investing.com/news/stock-market-news/raymond-james-initiates-smci-coverage-with-outperform-rating-on-ai-tailwinds-4826948">reported</a> Investing.com.
Raymond James highlighted that Supermicro has effectively carved out a niche for itself and &#8220;positioned itself in a sweet spot&#8221; between traditional branded IT vendors such as Dell (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>), Hewlett-Packard Enterprise (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPE#NYSE">HPE</a>) and contract manufacturers like Quanta.
The firm noted that while Supermicro has shown impressive growth, its valuation was impacted by past performance inconsistencies and internal control issues, which caused delayed SEC filings and auditor changes. These problems have since been resolved with no misconduct found.
SEE ALSO:&nbsp;<a href="https://benzinga.com/news/25/05/45378544/trump-administration-funneling-money-to-private-prison-companies-aoc-says-calling-out-profits-from-ice-deten" target="_blank" rel="noreferrer noopener">&#8216;Trump Administration Funneling Money To Private Prison Companies&#8217; AOC Says, Calling Out Profits From ICE Detentions After Campaign Kickbacks</a>
Why It Matters:&nbsp;Supermicro&#8217;s financial performance has been<a href="https://www.benzinga.com/news/earnings/25/05/45236823/super-micro-computer-stock-slips-after-q3-results-uncertainty-and-tariffs-may-have-a-short-term-impact-ceo-says"> under scrutiny</a>, especially following its Q3 results in 2025. The company reported quarterly earnings of 31 cents per share, missing the analyst consensus estimate of 50 cents by 38%. Its quarterly revenue of $4.6 billion also fell short of the analyst consensus estimate of $5.42 billion by 15.1%.
CEO Charles Liang said the company isn&#8217;t providing fiscal 2026 guidance due to tariff-related uncertainty, noting that "economic uncertainty and tariff impacts may have a short-term impact,&#8221; reported CNBC.
Despite these financial setbacks, Raymond James remains optimistic about Supermicro&#8217;s future, particularly due to its robust position in the AI-optimized infrastructure sector. The firm&#8217;s bullish stance is further supported by Supermicro&#8217;s plans to expand&nbsp;its U.S. manufacturing to produce&nbsp;1,500 liquid-cooled AI racks per&nbsp;month.
SMCI stock surged 16.02% to close at $38.89 on Tuesday. On a year-to-date basis, it soared over 29%.
SMCI holds a momentum rating of 40.25% and a growth rating of 93.38%, according to&nbsp;<a href="https://www.benzinga.com/quote/SMCI" target="_blank" rel="noreferrer noopener">Benzinga&#8217;s Proprietary Edge Rankings</a>. The Benzinga Growth metric evaluates a stock's historical earnings and revenue expansion across multiple timeframes, prioritizing both long-term trends and recent performance.
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://benzinga.com/news/25/05/45314762/charlie-munger-was-once-asked-why-warren-buffett-was-so-much-richer-and-replied-he-got-an-earlier-start-before-adding-why-was-albert-einstein-poorer-than-i-was" target="_blank" rel="noreferrer noopener">Charlie Munger Was Once Asked Why Warren Buffett Was So Much Richer — He Replied, &#8216;He Got An Earlier Start,&#8217; Then Added, &#8216;Why Was Albert Einstein Poorer Than I Was?&#8217; &#8211; Benzinga</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

News

Markets

Tech

DELL

SMCI

SMCI Stock In 'Sweet Spot,' Says Raymond James — Sets $41 Price Target As AI Revenue Hits 70%

Munchener (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MURGY#OTC">MURGY</a>) reported quarterly earnings of $0.88 per share. This is a 151.43 percent increase over earnings of $0.35 per share from the same period last year. The company reported $16.63 billion in sales this quarter. This is a 1.65 percent increase over sales of $16.36 billion the same period last year.

Earnings

MURGY

Munchener Q1 EPS $0.88 Up From $0.35 YoY, Sales $16.63B Up From $16.36B YoY

Google Cloud helps streamline marketing processes, enhancing brand consistency and reducing operational costs

GOOG

Google Cloud And Philips Partner To Transform Global Marketing With AI-Powered Digital Asset Management

Healthier Choices Mgmt (OTC:<a class="ticker" href="https://www.benzinga.com/stock/HCMC#OTC">HCMC</a>) reported $1.78 thousand in sales this quarter. This is a 1.40K percent increase over sales of $119.00 the same period last year.

HCMC

Healthier Choices Mgmt Q1 Sales $1.78K Up From $119.00 YoY

Once fully implemented, the company expects that more than 2,400 Hubexo employees across 25 countries in Europe, North America, and Asia Pacific will be live on the Dayforce platform.
"Global organisations face unique challenges, from managing a disparate workforce to remaining compliant across multiple jurisdictions. That's why companies like Hubexo choose Dayforce to deliver operational resiliency and simplicity at scale," said Nicole Bello, Group Vice President, EMEA, Dayforce, Inc. "By fully harnessing our AI-powered people platform, Hubexo is elevating their people processes to make work life better - and we're proud to partner with them on this transformational journey."

Dayforce Chosen By Hubexo To Standardize HR Operations And Power Workforce Across Europe, North America, And Asia Pacific

After Robinhood Markets Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) announced the acquisition of a Canadian cryptocurrency platform, WonderFi Technologies Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/WONDF#OTC">WONDF</a>), renowned entrepreneur and investor Kevin O&#8217;Leary expressed his excitement over the deal.
What Happened: O&#8217;Leary, who was one of the founding shareholders of WonderFi, said in an X post that he &#8220;couldn't be more excited&#8221; by this announcement.
According to the company statement, the <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45372870/robinhood-to-acquire-canadas-wonderfi-for-178m-all-cash-deal">purchase price</a> of $0.26 per share represents a 41% premium over WonderFi&#8217;s closing price on May 12 and a 71% premium over its 30-day volume-weighted average price.
O&#8217;Leary stated that this deal is going to transform cross-border trading. &#8220;We're finally connecting crypto between Canada and the U.S. right before stablecoin regulations hit. FX trading is about to get a major upgrade,&#8221; he said.
He also added that the deal will lead to &#8220;No more outrageous bank fees. You'll be able to move money between your Canadian and U.S. accounts instantly and at a fraction of the cost.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Exciting News! <a href="https://twitter.com/RobinhoodApp?ref_src=twsrc%5Etfw">@RobinhoodApp</a> is acquiring <a href="https://twitter.com/WonderFi?ref_src=twsrc%5Etfw">@WonderFi</a> and I couldn't be more excited. Why? This deal is going to transform cross-border trading. We're finally connecting crypto between Canada and the U.S. right before stablecoin regulations hit. FX trading is about to get a major… <a href="https://t.co/KHA4q7xWxn">pic.twitter.com/KHA4q7xWxn</a>
&mdash; Kevin O&#39;Leary aka Mr. Wonderful (@kevinolearytv) <a href="https://twitter.com/kevinolearytv/status/1922444818329796767?ref_src=twsrc%5Etfw">May 14, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/25/05/45367861/ed-yardeni-revises-recession-odds-to-25-after-the-rally-bumps-sp-500-year-end-target-to-6500">Ed Yardeni Slashes Recession Odds To 25% After US Stocks Rally, Lifts S&amp;P 500 Year-End Target To 6,500</a>
Why It Matters: WonderFi operates Canadian-regulated crypto exchanges Bitbuy and Coinsquare, which hold $1.49 billion in assets under custody.
The deal is anticipated to close in the latter half of 2025 pending approvals, and without any changes in its leadership team.
This acquisition will expand Robinhood&#8217;s Canadian crypto presence, adding to its existing Toronto headquarters and workforce of over 140.
The combined equity value of the transaction, on a fully diluted basis, stands at approximately $178 million. Advisors on the deal include&nbsp;J.P. Morgan Securities&nbsp;for Robinhood and&nbsp;Financial Technology Partners&nbsp;for WonderFi.
Price Action: Robinhood <a href="https://www.benzinga.com/news/global/25/05/45390595/robinhood-shares-jump-nearly-10-following-acquisition-deal-for-wonderfi-whats-going-on">shares rose</a> 8.95% on Tuesday, whereas Invesco QQQ Trust, Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), tracking the Nasdaq 100 index, advanced 1.52% during the same session.
The stock has risen 58.65% on a year-to-date basis and 247.23% over a year. WonderFi shares, on the other hand, jumped 35.54% on Tuesday.
Benzinga Edge Stock Rankings shows that HOOD had a stronger price trend over the short, medium, and long term. Its momentum ranking was solid at 98.62th percentile, whereas its value ranking was poor at 19.71th percentile; the details of other metrics are <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">available here</a>. 
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/HOOD"><img loading="lazy" decoding="async" width="1024" height="144" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14021609/HOOD-Edge-1024x144.png" alt="" class="wp-image-914438" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14021609/HOOD-Edge-1024x144.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14021609/HOOD-Edge-300x42.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14021609/HOOD-Edge-768x108.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14021609/HOOD-Edge.png 1219w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45371290/chamath-palihapitiya-questions-ai-funding-after-swedish-bnpl-firm-klarna-rolls-back-ai-bets-startups-could-pivot-to-simply-use-ai-for-narrow-use-cases">Chamath Palihapitiya Says Swedish Fintech Company Klarna Scaling Back AI Support Is A Red Flag For Industry: Startups Could &#8216;Pivot To Simply Use AI For Narrow Use Cases&#8217;</a></li>
</ul>
Photo Courtesy: Sergei Elagin On Shutterstock.com

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

Market Summary

Broad U.S. Equity ETFs

Futures

ETFs

General

HOOD

WONDF

Kevin O'Leary Lauds Robinhood's Acquisition Of WonderFi Will 'Transform Cross-Border Trading:' 'No More Outrageous Bank Fees'

Steel Partners Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPLP#NYSE">SPLP</a>) reported quarterly earnings of $1.41 per share. This is a 6 percent decrease over earnings of $1.50 per share from the same period last year. The company reported $499.22 million in sales this quarter. This is a 4.80 percent increase over sales of $476.35 million the same period last year.

SPLP

Steel Partners Holdings Q1 EPS $1.41 Down From $1.50 YoY, Sales $499.22M Up From $476.35M YoY

TLGPY

Reported Earlier, Telstra, Accenture Open First-of-Its-Kind AI Innovation Hub In Silicon Valley To Power Intelligent Systems And Agentic AI

<ul>
<li>Junichi Nakagawa and Samuel Zou appointed Sales Directors for Cboe Data Vantage in Asia Pacific</li>
<li>Hires reflect growing demand for data, analytics and related services in the region, facilitating access to U.S. and European markets</li>
<li>Expansion supports&nbsp;Cboe's ongoing global growth strategy for Data Vantage</li>
</ul>

CBOE

Reported Earlier, Cboe Strengthens Asia Pacific Presence With Key Hires Amid Surging Demand For U.S. And European Market Access

In addition, the Company has entered into a privately negotiated agreement with the holder of certain existing outstanding warrants to purchase up to 167,925 shares of common stock (the "Existing Warrants") to reduce the exercise price of such Existing Warrants from $41.20 per share to $7.45 per share.

HCWB

Reported Earlier, HCW Biologics Announces $5M Offering of 671,140 Units At $7.45 Per Unit Under Nasdaq Rules

The Rights Agreement is intended to reduce the likelihood that any entity, person or group is able to gain control of TrueBlue through open market accumulation without paying all shareholders an appropriate control premium or providing the Board with sufficient opportunity to make informed judgments and take actions in the best interests of all shareholders.

Reported Earlier, TrueBlue Adopts Limited Duration Shareholder Rights Plan Following Unsolicited $7.50 Per Share Offer From HireQuest

DA Davidson analyst&nbsp;Gil Luria&nbsp;has proposed that&nbsp;Alphabet Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) should contemplate splitting up Google&#8217;s various businesses to enhance its overall value. This recommendation comes amid Google&#8217;s struggle to retain its supremacy in the search engine market due to the rise of AI chatbots.
What Happened: Luria, in an <a href="https://finance.yahoo.com/news/google-needs-big-bang-breakup-that-would-value-its-businesses-at-37-trillion-as-ai-threatens-search-analyst-171143842.html">interview</a> with Yahoo Finance, has expressed that Google&#8217;s resistance to a breakup is contributing to its unusually low earnings multiple for a growth company. The U.S. Department of Justice has previously called on Google to divest its Chrome browser and advertising network and potentially its mobile Android division as well.
Luria&#8217;s clients, a broad spectrum of institutional investors, are pushing for a &#8220;big bang breakup&#8221; rather than &#8220;isolated spinoffs&#8221;. Luria suggests that Google should divide its businesses into individually traded entities.
According to Luria&#8217;s analysis, Google&#8217;s&nbsp;individual businesses would be valued&nbsp;much higher as separate entities. While Google&#8217;s market capitalization is currently less than $2 trillion, Luria estimates that the total value of Google&#8217;s&nbsp;businesses, when valued separately, would&nbsp;be $3.7 trillion.
The analyst proposes that Google should separate&nbsp;YouTube, Search, Google Cloud, Waymo and its AI segments. He contends that Alphabet&#8217;s stock is currently trading at a historically low valuation—just 16 times its forward earnings—significantly below the overall market multiple.
Luria also stated that Google&#8217;s individual businesses would trade at levels comparable to their peers, with Waymo comparable to&nbsp;Uber&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>), Google Cloud to&nbsp;Snowflake&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>), YouTube to&nbsp;Netflix&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>)&nbsp;and Google's TPU business to&nbsp;Nvidia&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>).
SEE ALSO:&nbsp;<a href="https://benzinga.com/25/05/45395189/mark-cuban-takes-a-jab-at-howard-lutnick-in-which-time-share-company-is-he-going-to-get-a-job-in-sales-at" target="_blank" rel="noreferrer noopener">Mark Cuban Takes A Jab At Howard Lutnick, &#8216;In Which Time Share Company Is He Going To Get A Job In Sales At&#8217;</a>
Why It Matters: Google&#8217;s current predicament can be traced back to May 8, when it <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45288753/google-at-staggering-42-discount-to-sp-500-after-150-billion-value-dive">experienced </a>one of its worst trading days since 2023, losing over 7% and nearly $150 billion in market cap. This massive loss was triggered by a statement from Apple Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) Eddy Cue, who revealed a decline in search volume on iPhones, an event that hadn&#8217;t occurred in 20 years.
This revelation sparked a debate on the All-In Podcast, where <a href="https://www.benzinga.com/25/05/45339953/apple-exec-says-iphone-users-are-ditching-google-search-now-chamath-palihaptiya-urges-the-tech-giant-to-stop-waiting-for-data-and-start-fighting-models-like-chatgpt">venture capitalist</a> Chamath Palihapitiya urged Google to stop waiting for data and start fighting models like ChatGPT.
Luria&#8217;s &#8220;big bang breakup&#8221; is seen as a strategic suggestion for Google to regain its lost ground and boost its overall value in the face of these challenges.
Benzinga's Edge Rankings place Alphabet in the 81st percentile for quality and the 67th percentile for growth, reflecting its strong performance in both areas. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Check the detailed report here.</a>
Over the past 5 days, Alphabet stock declined 3.07%, while year to date it plunged 15.6%.
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://benzinga.com/news/25/05/45314762/charlie-munger-was-once-asked-why-warren-buffett-was-so-much-richer-and-replied-he-got-an-earlier-start-before-adding-why-was-albert-einstein-poorer-than-i-was" target="_blank" rel="noreferrer noopener">Charlie Munger Was Once Asked Why Warren Buffett Was So Much Richer — He Replied, &#8216;He Got An Earlier Start,&#8217; Then Added, &#8216;Why Was Albert Einstein Poorer Than I Was?&#8217; &#8211; Benzinga</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

AAPL

GOOGL

NFLX

NVDA

SNOW

UBER

Alphabet's Value Could Skyrocket To $3.7 Trillion With Google's 'Big Bang Breakup' Over 'Isolated Spin-Offs,' Says Analyst

Editor&#8217;s Note: The story has been updated with Amazon&#8217;s statement.
The Federal Trade Commission has accused Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) of concealing key evidence in the antitrust case that claims the <a href="https://www.benzinga.com/government/regulations/25/01/42822625/big-techs-date-with-antitrust-alphabet-meta-amazon-brace-for-legal-showdowns-in-2025">retail giant abused its market power</a>. As per a new court filing, the FTC says Amazon withheld thousands of non-privileged documents by incorrectly labeling them as protected.
What Happened: Following an order by a federal judge to re-review its privilege claims, Amazon withdrew 92% of them and presented around 70,000 documents it had withheld earlier, according <a href="https://www.courthousenews.com/ftc-accuses-amazon-of-hiding-evidence-in-antitrust-case/">to</a> the Courthouse News Service. 
The FTC discovered that around 75% of those had been completely shielded from view. In a small in-camera review, a single sentence out of nine documents was deemed privileged. 
One document quoted a top executive calling founder and former CEO Jeff Bezos Amazon's "chief dark arts officer" when describing the "shady world" of tactics employed to boost Prime subscriptions, the report noted.
See Also: <a href="https://www.benzinga.com/government/regulations/25/05/45331065/the-trade-desk-ceo-slams-google-amazons-walled-gardens-imagine-what-we-can-do-in-a-fair-market">The Trade Desk CEO Slams Google, Amazon&#8217;s &#8216;Walled Gardens&#8217;: &#8216;Imagine What We Can Do In A Fair Market&#8217;</a>
Why It Matters: The FTC says these documents were withheld not because they were legally protected, but because they &nbsp;damaging evidence. "In essence, Amazon's privilege log — on which the FTC has relied throughout discovery — was almost entirely wrong," the commission wrote in its motion. "It is impossible to square a 92% error rate across tens of thousands of documents with a mere mistake."
The commission also said that Amazon has a pattern of falsely labeling routine communications as "privileged" and alleged that the company instructs staff to mislabel documents to sidestep regulatory scrutiny. "The blatant nature and ubiquity of these actions demonstrate&#8230; a purposeful plan," the FTC added.
Calling the withheld records &#8220;probative, inculpatory, and entirely nonprivileged,&#8221; the FTC has asked the court for another 90 days of discovery and for Amazon to bear the resulting costs. 
&#8220;The FTC wants to distract from the facts because the facts don't support this vague and unprecedented legal case,&#8221; an Amazon spokesperson told Benzinga in a statement.
Regarding the meeting notes that reference "dark arts," the spokesperson added: &#8220;These notes are from a much longer conversation that included discussion about non-Amazon subscription programs. The way Amazon drives Prime subscribers is by making the service useful and valuable. It is correct that an element of driving that value is an art rather than a science. And our approach works — Prime, with hundreds of millions of members, is among the highest-performing subscription programs of any kind, as measured by renewal rates and customer satisfaction.&#8221;
Amazon is not the only tech giant locking horns with the FTC. Last month, hearings began as part of the FTC's <a href="https://www.benzinga.com/news/25/04/44888906/meta-faces-an-antitrust-lawsuit-ftc-says-company-holds-a-social-network-monopoly">antitrust lawsuit against Meta</a>.
Amid these high-profile cases, the FTC is also facing a shortage of resources due <a href="https://www.benzinga.com/government/regulations/25/03/44310724/doge-cuts-to-ftc-sow-confusion-in-case-against-amazon">to cuts enacted by DOGE</a>.
Image Via Shutterstock
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45356821/why-amazons-robot-army-could-save-10-billion-and-change-your-delivery-game">Why Amazon&#8217;s Robot Army Could Save $10 Billion And Change Your Delivery Game</a></li>
</ul>

Legal

AMZN

Jeff Bezos Called 'Chief Dark Arts Officer' In Secret Amazon Doc As FTC Says Company Hid Thousands Of Key Files In Antitrust Case (UPDATED)

Endava plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAVA#NYSE">DAVA</a>) will release earnings results for the third quarter, before the opening bell on <a href="https://www.benzinga.com/quote/DAVA/earnings">Wednesday, May 14</a>.
Analysts expect the UK-based company to report quarterly earnings at 31 cents per share, compared to 22 cents per share in the year-ago period. Endava projects to report quarterly revenue at $197.84 million, compared to $174.37 million a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Feb. 20, Endava reported better-than-expected second-quarter financial results.
Endava shares fell 0.4% to close at $21.41 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/DAVA/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Needham analyst Mayank Tandon maintained a Buy rating and cut the price target from $43 to $38 on Feb. 21, 2025. This analyst has an accuracy rate of 68%.</li>
<li>Morgan Stanley analyst James Faucette maintained an Equal-Weight rating and raised the price target from $33 to $35 on Jan. 31, 2025. This analyst has an accuracy rate of 66%.</li>
<li>B of A Securities analyst Tyler DuPont initiated coverage on the stock with a Neutral rating and a price target of $29 on Nov. 22, 2024. This analyst has an accuracy rate of 61%.</li>
<li>TD Cowen analyst Bryan Bergin maintained a Buy rating and raised the price target from $35 to $36 on Nov. 13, 2024. This analyst has an accuracy rate of 63%.</li>
<li>Citigroup analyst Ashwin Shirvaikar maintained a Neutral rating and cut the price target from $30 to $27 on Oct. 28, 2024. This analyst has an accuracy rate of 74%.</li>
</ul>
Considering buying DAVA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="578" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14024558/image-150-1024x578.png" alt="" class="wp-image-914479" style="width:606px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14024558/image-150-1024x578.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14024558/image-150-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14024558/image-150-768x433.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14024558/image-150.png 1117w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45375319/jim-cramer-ok-harrow-recommends-buying-this-energy-stock">Jim Cramer Is &#8216;OK&#8217; With Harrow, Recommends Buying This Energy Stock</a> </li>
</ul>
Photo via Shutterstock

Price Target

Pre-Market Outlook

Analyst Ratings

Trading Ideas

DAVA

Top Wall Street Forecasters Revamp Endava Expectations Ahead Of Q3 Earnings

Broadridge Secures U.S. Patent For Large Language Model Orchestration Powering BondGPT And Enterprise AI Trading Tools

<ul>
<li>Affecting up to 5% of the global population, SLD represents an area of significant unmet medical need with limited treatment options</li>
<li>Phase II data show potential of efimosfermin to reverse liver fibrosis, demonstrated in metabolic dysfunction-associated steatohepatitis (a form of SLD)</li>
<li>Unique properties offer potential for efimosfermin to be a new standard-of-care</li>
<li>Significantly expands GSK's hepatology pipeline aimed at addressing steatotic and viral drivers of liver disease, offering multiple development options and potential first launch in 2029</li>
</ul>

Macro Economic Events

Econ #s

Economics

INDA

India Wholesale Price Index (WPI) Inflation (YoY) For April 0.85% Vs. 1.76% Est.; 2.05% Prior

<ul>
<li>Marks FirstCash's strategic entry into the UK market through an established, industry-leading brand;</li>
<li>Provides further geographic diversification and unlocks additional growth opportunities;</li>
<li>Expected to be meaningfully accretive to EBITDA and EPS;</li>
<li>Strengthens FirstCash's position as a global leader in pawn operations</li>
</ul>

FCFS

FirstCash To Acquire H&T Group For $394M In UK Expansion Deal Expected To Deliver Meaningful EBITDA And EPS Accretion

GSK To Expand Liver Disease Portfolio With $1.2B Acquisition Of Boston Pharmaceuticals' Efimosfermin, Targeting 2029 Launch

Dynatrace, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DT#NYSE">DT</a>) will release earnings results for the fourth quarter, before the opening bell on <a href="https://www.benzinga.com/quote/DT/earnings">Wednesday, May 14.</a>
Analysts expect the Waltham, Massachusetts-based company to report quarterly earnings at 30 cents per share, compared to 30 cents per share in the year-ago period. Dynatrace projects to report quarterly revenue at $435.14 million, compared to $380.85 million a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On April 22, Dynatrace announced that Steve McMahon will join Dynatrace as its new Chief Customer Officer.
Dynatrace shares gained 0.1% to close at $50.54 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/DT/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Rosenblatt analyst Blair Abernethy maintained a Buy rating with a price target of $67 on May 13, 2025. This analyst has an accuracy rate of 70%.</li>
<li>UBS analyst Karl Keirstead maintained a Neutral rating and slashed the price target from $62 to $50 on April 30, 2025. This analyst has an accuracy rate of 76%.</li>
<li>Loop Capital analyst Yun Kim maintained a Hold rating and cut the price target from $55 to $44 on April 23, 2025. This analyst has an accuracy rate of 78%.</li>
<li>Barclays analyst Raimo Lenschow maintained an Overweight rating and lowered the price target from $67 to $55 on April 21, 2025. This analyst has an accuracy rate of 70%.</li>
<li>Jefferies analyst Brent Thill maintained a Buy rating and cut the price target from $65 to $60 on April 7, 2025. This analyst has an accuracy rate of 77%.</li>
</ul>
Considering buying DT stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="583" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14022507/image-149-1024x583.png" alt="" class="wp-image-914449" style="width:606px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14022507/image-149-1024x583.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14022507/image-149-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14022507/image-149-768x437.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14022507/image-149.png 1112w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45375319/jim-cramer-ok-harrow-recommends-buying-this-energy-stock">Jim Cramer Is &#8216;OK&#8217; With Harrow, Recommends Buying This Energy Stock</a> </li>
</ul>
Photo via Shutterstock

Dynatrace Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Valeura Energy (TSX:<a class="ticker" href="https://www.benzinga.com/stock/VLE#TSX">VLE</a>) reported quarterly earnings of $0.13 per share which missed the analyst consensus estimate of $0.26 by 50 percent. This is a 27.78 percent decrease over earnings of $0.18 per share from the same period last year. The company reported $148.08 million in sales this quarter. This is a 0.89 percent decrease over sales of $149.41 million the same period last year.

Earnings Misses

TSX:VLE

VLERF

Valeura Energy Q1 EPS $0.13 Misses $0.26 Estimate, Sales $148.08M Down From $149.41M YoY

Health Care

Press Releases

Mainz Biomed Initiates U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population

Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements

Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month

Mainz Biomed Expands into Switzerland with labor team w

Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention

Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer

Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study

Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update

Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval

Mainz Biomed Enters into Technology Partnership with EDX Medical Group

MYNZ

AEON Biopharma, Inc. Class A Common Stock

AEON Biopharma

Apollomics Inc. - Class A Ordinary Shares

Apollomics

Aptorum Group Limited - Class A Ordinary Shares

Aptorum Group

180 Life Sciences

Azitra

Brainstorm Cell Therapeutics Inc. - Common Stock

Brainstorm Cell

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

Channel Therapeutics Corporation Common Stock

Channel Therapeutics

Dermata Therapeutics, Inc. - Common Stock

Dermata Therapeutics

GT Biopharma

HCW Biologics

Indaptus Therapeutics, Inc. - Common Stock

Indaptus Therapeutics

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences

Lipella Pharmaceuticals Inc. - Common Stock

Lipella Pharmaceuticals

MetaVia

Oragenics

PharmaCyte Biotech

Sunshine Biopharma

SILO Pharma

Soligenix

Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Sonnet BioTherapeutics

Alaunos Therapeutics, Inc. - Common Stock

Alaunos Therapeutics

Turnstone Biologics

Longevity Health Holdings, Inc. - Common Stock

Longevity Health Holdings

Xenetic Biosciences

Maxim Group

JonesTrading

Screenshot 2025-04-15 at 7.03.21 PM

Biotech

Mainz Biomed Narrows Its Losses, Grows Revenue For Full Year 2024

Screenshot 2025-04-02 at 9.29.30 PM

Mainz BioMed&#39;s Trial To Bring Critical Early Cancer Detection One Step Closer

Screenshot 2024-12-19 at 7.13.05 PM

Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S.

Screenshot 2024-11-21 at 6.41.48 PM

Mainz Biomed Inks Major Deal To Develop A Next-Generation Cancer Test

Screenshot 2024-11-12 at 8.43.58 PM

Healthcare Giant Thermo Fisher Scientific Inc. (NYSE: TMO) Inks Deal With Mainz Biomed (NASDAQ: MYNZ) To Develop And Commercialize Next Gen Colorectal Cancer Screening

Screenshot 2024-11-11 at 7.48.49 PM

What Mainz Biomed (NASDAQ: MYNZ) Has Been Up To Recently And Why Frankie Muniz Is A Backer

Screenshot 2024-10-04 at 11.57.48 PM

Interview

Former Senior Advisor To Obama Joins Forces With Innovative Biotech To Catch Cancer Early

Screenshot 2024-09-04 at 5.52.15 PM

Mainz Biomed (NASDAQ: MYNZ) And Liquid Biosciences Team Up To Fight Pancreatic Cancer With Early Detection Tool

Screenshot 2024-08-30 at 2.55.26 PM

Emerging Markets

Early Cancer Detection Saves Lives - This Biotech Has A Promising New Test

Screenshot 2024-08-30 at 6.27.59 PM

EXAS

Mainz Biomed Seeks FDA Approval For Colorectal Cancer Test It Says Is Nearly Twice As Sensitive As Others – A Look At Pipeline And Milestones

Comments

Mainz Biomed

Actualités

Dernières nouvelles pour Mainz Biomed (NASDAQ:MYNZ) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL